- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-12-mer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 6 x E17: N-{(1S,2S)-1-benzyl-3-[(4R)-5,5-dimethyl-4-{[(1R)-1,2,2-trimethylpropyl]carbamoyl}-1,3-thiazolidin-3-yl]-2-hydroxy-3-oxopropyl}-3-methyl-N~2~-{(2S)-2-[(morpholin-4-ylacetyl)amino]-2-phenylacetyl}-L-valinamide(Non-covalent)
E17.2: 24 residues within 4Å:- Chain A: R.10, D.32, G.34, A.35, M.37, V.39, V.56, L.57, A.59, L.91, W.98, I.100
- Chain B: R.10, L.30, D.32, G.34, A.35, D.36, M.37, V.56, L.57, G.58, A.59, Q.62
23 PLIP interactions:14 interactions with chain B, 9 interactions with chain A- Hydrophobic interactions: B:L.30, B:V.56, B:L.57, B:L.57, B:A.59, A:A.35, A:V.39, A:V.56, A:A.59, A:W.98, A:W.98, A:I.100
- Hydrogen bonds: B:D.32, B:G.34, B:G.34, B:D.36, B:D.36, B:D.36, B:L.57, B:L.57
- Water bridges: B:A.59, A:A.59
- pi-Cation interactions: A:R.10
E17.4: 24 residues within 4Å:- Chain C: R.10, D.32, G.34, A.35, M.37, V.39, V.56, L.57, A.59, L.91, W.98, I.100
- Chain D: R.10, L.30, D.32, G.34, A.35, D.36, M.37, V.56, L.57, G.58, A.59, Q.62
23 PLIP interactions:9 interactions with chain C, 14 interactions with chain D- Hydrophobic interactions: C:A.35, C:V.39, C:V.56, C:A.59, C:W.98, C:W.98, C:I.100, D:L.30, D:V.56, D:L.57, D:L.57, D:A.59
- Water bridges: C:A.59, D:A.59
- pi-Cation interactions: C:R.10
- Hydrogen bonds: D:D.32, D:G.34, D:G.34, D:D.36, D:D.36, D:D.36, D:L.57, D:L.57
E17.6: 24 residues within 4Å:- Chain E: R.10, D.32, G.34, A.35, M.37, V.39, V.56, L.57, A.59, L.91, W.98, I.100
- Chain F: R.10, L.30, D.32, G.34, A.35, D.36, M.37, V.56, L.57, G.58, A.59, Q.62
23 PLIP interactions:9 interactions with chain E, 14 interactions with chain F- Hydrophobic interactions: E:A.35, E:V.39, E:V.56, E:A.59, E:W.98, E:W.98, E:I.100, F:L.30, F:V.56, F:L.57, F:L.57, F:A.59
- Water bridges: E:A.59, F:A.59
- pi-Cation interactions: E:R.10
- Hydrogen bonds: F:D.32, F:G.34, F:G.34, F:D.36, F:D.36, F:D.36, F:L.57, F:L.57
E17.8: 24 residues within 4Å:- Chain G: R.10, D.32, G.34, A.35, M.37, V.39, V.56, L.57, A.59, L.91, W.98, I.100
- Chain H: R.10, L.30, D.32, G.34, A.35, D.36, M.37, V.56, L.57, G.58, A.59, Q.62
22 PLIP interactions:13 interactions with chain H, 9 interactions with chain G- Hydrophobic interactions: H:L.30, H:V.56, H:L.57, H:L.57, H:A.59, G:A.35, G:V.39, G:V.56, G:A.59, G:W.98, G:W.98, G:I.100
- Hydrogen bonds: H:D.32, H:G.34, H:G.34, H:D.36, H:D.36, H:L.57, H:L.57
- Water bridges: H:A.59, G:A.59
- pi-Cation interactions: G:R.10
E17.10: 24 residues within 4Å:- Chain I: R.10, D.32, G.34, A.35, M.37, V.39, V.56, L.57, A.59, L.91, W.98, I.100
- Chain J: R.10, L.30, D.32, G.34, A.35, D.36, M.37, V.56, L.57, G.58, A.59, Q.62
22 PLIP interactions:9 interactions with chain I, 13 interactions with chain J- Hydrophobic interactions: I:A.35, I:V.39, I:V.56, I:A.59, I:W.98, I:W.98, I:I.100, J:L.30, J:V.56, J:L.57, J:L.57, J:A.59
- Water bridges: I:A.59, J:A.59
- pi-Cation interactions: I:R.10
- Hydrogen bonds: J:D.32, J:G.34, J:G.34, J:D.36, J:D.36, J:L.57, J:L.57
E17.12: 24 residues within 4Å:- Chain K: R.10, D.32, G.34, A.35, M.37, V.39, V.56, L.57, A.59, L.91, W.98, I.100
- Chain L: R.10, L.30, D.32, G.34, A.35, D.36, M.37, V.56, L.57, G.58, A.59, Q.62
22 PLIP interactions:13 interactions with chain L, 9 interactions with chain K- Hydrophobic interactions: L:L.30, L:V.56, L:L.57, L:L.57, L:A.59, K:A.35, K:V.39, K:V.56, K:A.59, K:W.98, K:W.98, K:I.100
- Hydrogen bonds: L:D.32, L:G.34, L:G.34, L:D.36, L:D.36, L:L.57, L:L.57
- Water bridges: L:A.59, K:A.59
- pi-Cation interactions: K:R.10
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Satoh, T. et al., Crystal structures of inhibitor complexes of human T-cell leukemia virus (HTLV-1) protease. J.Mol.Biol. (2010)
- Release Date
- 2010-07-14
- Peptides
- Protease: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
BI
AJ
BK
AL
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-12-mer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 6 x E17: N-{(1S,2S)-1-benzyl-3-[(4R)-5,5-dimethyl-4-{[(1R)-1,2,2-trimethylpropyl]carbamoyl}-1,3-thiazolidin-3-yl]-2-hydroxy-3-oxopropyl}-3-methyl-N~2~-{(2S)-2-[(morpholin-4-ylacetyl)amino]-2-phenylacetyl}-L-valinamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Satoh, T. et al., Crystal structures of inhibitor complexes of human T-cell leukemia virus (HTLV-1) protease. J.Mol.Biol. (2010)
- Release Date
- 2010-07-14
- Peptides
- Protease: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
BI
AJ
BK
AL
B